South Korea Non Invasive Prenatal Testing Market Size & Outlook

The non invasive prenatal testing market in South Korea is expected to reach a projected revenue of US$ 131.9 million by 2030. A compound annual growth rate of 11.3% is expected of South Korea non invasive prenatal testing market from 2023 to 2030.

Revenue, 2022 (US$M)
$56.1
Forecast, 2030 (US$M)
$131.9
CAGR, 2023 - 2030
11.3%
Report Coverage
South Korea

South Korea non invasive prenatal testing market, 2018-2030 (US$M)

South

Related Markets

South Korea non invasive prenatal testing market highlights

  • The South Korea non invasive prenatal testing market generated a revenue of USD 56.1 million in 2022 and is expected to reach USD 131.9 million by 2030.
  • The South Korea market is expected to grow at a CAGR of 11.3% from 2023 to 2030.
  • In terms of segment, 13-24 weeks was the largest revenue generating gestation period in 2022.
  • 0-12 weeks is the most lucrative gestation period segment registering the fastest growth during the forecast period.


Non invasive prenatal testing market data book summary

Market revenue in 2022USD 56.1 million
Market revenue in 2030USD 131.9 million
Growth rate11.3% (CAGR from 2022 to 2030)
Largest segment13-24 weeks
Fastest growing segment0-12 weeks
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentation0-12 weeks, 13-24 weeks, 25-36 weeks
Key market players worldwideCooperSurgical, Natera Inc, Eurofins Scientific SE, Illumina Inc, Centogene NV Ordinary Shares, MedGenome, Myriad Genetics Inc, Roche Holding AG, Qiagen NV, Labcorp Holdings Inc, Quest Diagnostics Inc, Biora Therapeutics


Other key industry trends

  • In terms of revenue, South Korea accounted for 1.5% of the global non invasive prenatal testing market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China non invasive prenatal testing market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 242.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Non Invasive Prenatal Testing Market Scope

Non invasive prenatal testing market segmentation & scope
0-12 weeks
13-24 weeks
25-36 weeks
High & Average Risk
Low Risk
Ultrasound Detection
Biochemical Screening Tests
Cell-Free DNA in Maternal Plasma Tests
NGS
Array Technology
PCR
Others
Consumables & Reagents
Instruments
Trisomy
Microdeletion Syndrome
Other Applications
Hospitals & Clinics
Diagnostic Laboratories

Non Invasive Prenatal Testing Market Companies

Name Profile # Employees HQ Website

South Korea non invasive prenatal testing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non invasive prenatal testing market will help companies and investors design strategic landscapes.


13-24 weeks was the largest segment with a revenue share of 52.41% in 2022. Horizon Databook has segmented the South Korea non invasive prenatal testing market based on 0-12 weeks, 13-24 weeks, 25-36 weeks covering the revenue growth of each sub-segment from 2018 to 2030.


In South Korea, the proportion of elderly pregnant women has dramatic rise in elderly pregnancy has raised worries about the high risk of fetal aneuploidies. In South Korea, the expected number of infants with Down syndrome is 4.5 per 10,000 births. According to South Korean government statistics, more than 97.5% of pregnant women are given some form of serum screening test for detecting fetal aneuploidies during pregnancy. Increasing R&D investments by key pharmaceutical companies in South Korea are expected to create a lucrative environment for market growth. For instance, in December 2019, Roche Diagnostics Korea announced plans to encourage the use of a non-invasive prenatal test (NIPT) in the Korean market. In 2016, the business launched its NIPT, Harmony, in the local market. To send retrieved samples to U.S. testing institutions and receive results, the firm used the "test and send out" (TSO) technique. 

Reasons to subscribe to South Korea non invasive prenatal testing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of South Korea non invasive prenatal testing market databook

  • Our clientele includes a mix of non invasive prenatal testing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the South Korea non invasive prenatal testing market , including forecasts for subscribers. This country databook contains high-level insights into South Korea non invasive prenatal testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

South Korea non invasive prenatal testing market size, by gestation period, 2018-2030 (US$M)

South Korea Non Invasive Prenatal Testing Market Outlook Share, 2022 & 2030 (US$M)

South Korea non invasive prenatal testing market size, by gestation period, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more